Drugs Made In America Acquisition DMII Balance Sheet (2024-2026)

NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT
Reported Financials

Drugs Made In America Acquisition Quarterly Balance Sheet

Periods 4 quarters
Latest Jun 2026

Drugs Made In America Acquisition reported total assets of $514.10M and total liabilities of $532.03M for the quarter ended Jun 2026. This balance sheet covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2024 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.02M0.32M223.000.17M
Receivables - OtherOther Receivables 0.57M
Prepaid Assets 0.04M0.01M0.03M0.04M
Current Assets 0.06M0.90M0.03M0.22M
Non-Current Assets
Long-Term Investments 500.11M504.93M513.88M
Other Non-Current Assets 0.08M
Non-Current Assets 0.08M500.11M504.93M513.88M
Assets 0.14M501.01M504.96M514.10M
Liabilities
Current Liabilities
Accounts Payables 0.00M0.10M0.01M
Notes Payables 0.25M0.45M
Payables 0.25M0.00M0.10M0.46M
Accumulated Expenses 0.01M0.09M0.07M
Other Accumulated Expenses 0.55M
Total Current Liabilities 0.25M0.68M0.30M0.64M
Non-Current Liabilities
Preferred Stock Liabilities 500.11M504.93M513.88M
Other Non-Current Liabilities 17.50M17.50M17.50M
Total Non-Current Liabilities 500.79M17.50M17.50M
Total Liabilities 0.25M518.29M522.73M532.03M
Shareholder's Equity
Total Debt 0.25M0.45M
Common Equity -0.12M-17.28M-17.77M-17.93M
Liabilities and Shareholders Equity 0.14M501.01M504.96M514.10M
Retained Earnings -0.15M-17.28M-17.78M-17.93M

Drugs Made In America Acquisition Balance Sheet API

Pull Drugs Made In America Acquisition's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DMII&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY